SCTPF Financials Tuesday, July 15, 2014 06:25:38 A

SCTPF Financials Tuesday, July 15, 2014 06:25:38 AM
Trillium Therapeutics Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 3,140 626 2,294 2,643
Sales, General and Admin. 906 468 845 1,684
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,046) (1,095) (3,139) (4,328)
Income From Continuing Operations
Add'l Income/Expense Items 51 31 36 8
Earnings Before Interest and Tax (3,995) (1,064) (3,103) (4,320)
Interest Expense 42 2 14 14
Earnings Before Tax (4,037) (1,066) (3,117) (4,333)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,037) (1,066) (3,117) (4,333)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,037) (1,066) (3,117) (4,333)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,037) (1,066) (3,117) (4,333)